ABIVAX (EPA:ABVX) | Finanzwire

PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 11 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
BRIEF

published on 04/30/2024 at 18:05, 2 years ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
BRIEF

published on 04/05/2024 at 22:05, 2 years ago

Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies

Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
PRESS RELEASE

published on 04/05/2024 at 22:00, 2 years ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information

Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF

published on 04/02/2024 at 08:35, 2 years 1 month ago

Abivax Reports 2023 Financial Results and Operational Update

Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
PRESS RELEASE

published on 04/02/2024 at 08:30, 2 years 1 month ago

Abivax reports 2023 financial results and operational update
Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024

Financial Results Fundraising Abivax Webcast Operational Update
BRIEF

published on 03/27/2024 at 18:05, 2 years 1 month ago

ABIVAX publishes its number of shares and voting rights as of February 29, 2024

Euronext Paris Share Capital Voting Rights Abivax Regulation
BRIEF

published on 02/23/2024 at 18:00, 2 years 2 months ago

ABIVAX announces an update on its share capital and voting rights

Share Capital Voting Rights Biotechnology Abivax Financial Transparency
PRESS RELEASE

published on 02/13/2024 at 08:30, 2 years 2 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
Abivax to present four abstracts on obefazimod for ulcerative colitis at 19th ECCO Congress, including a sponsored symposium on emerging treatment mechanisms. Event details available on ECCO website

Abivax Obefazimod Ulcerative Colitis ECCO Congress Scientific Symposium
PRESS RELEASE

published on 02/07/2024 at 08:30, 2 years 2 months ago

Abivax appoints Ana Sharma as Vice President, Global Head of Quality
Abivax appoints Ana Sharma as Vice President, Global Head of Quality. Ana Sharma brings over 20 years of experience in the biopharmaceutical industry and has a strong track record in quality and GxP compliance

Abivax Ana Sharma Biopharmaceutical Industry Quality Compliance GxP

Published on 05/02/2026 at 21:00, 20 hours 49 minutes ago

GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 16 hours ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 16 hours ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 17 hours ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 17 hours ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

View all ACCESSWIRE

Published on 05/03/2026 at 04:45, 13 hours 4 minutes ago

GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 2 hours ago

Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 22 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 1 day 23 hours ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 2 days ago

Key Figures 30.04.2026

View all EQS

Published on 04/30/2026 at 20:00, 2 days 21 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 days 22 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 days 22 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 2 days 23 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 2 days 23 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News